Literature DB >> 23353891

A low mortality rat model to assess delayed cerebral vasospasm after experimental subarachnoid hemorrhage.

Rahul V Dudhani1, Michele Kyle, Christina Dedeo, Margaret Riordan, Eric M Deshaies.   

Abstract

OBJECTIVE: To characterize and establish a reproducible model that demonstrates delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH) in rats, in order to identify the initiating events, pathophysiological changes and potential targets for treatment.
METHODS: Twenty-eight male Sprague-Dawley rats (250 - 300 g) were arbitrarily assigned to one of two groups - SAH or saline control. Rat subarachnoid hemorrhage in the SAH group (n=15) was induced by double injection of autologous blood, 48 hr apart, into the cisterna magna. Similarly, normal saline (n=13) was injected into the cisterna magna of the saline control group. Rats were sacrificed on day five after the second blood injection and the brains were preserved for histological analysis. The degree of vasospasm was measured using sections of the basilar artery, by measuring the internal luminal cross sectional area using NIH Image-J software. The significance was tested using Tukey/Kramer's statistical analysis.
RESULTS: After analysis of histological sections, basilar artery luminal cross sectional area were smaller in the SAH than in the saline group, consistent with cerebral vasospasm in the former group. In the SAH group, basilar artery internal area (.056 μm ± 3) were significantly smaller from vasospasm five days after the second blood injection (seven days after the initial blood injection), compared to the saline control group with internal area (.069 ± 3; p=0.004). There were no mortalities from cerebral vasospasm.
CONCLUSION: The rat double SAH model induces a mild, survivable, basilar artery vasospasm that can be used to study the pathophysiological mechanisms of cerebral vasospasm in a small animal model. A low and acceptable mortality rate is a significant criterion to be satisfied for an ideal SAH animal model so that the mechanisms of vasospasm can be elucidated. Further modifications of the model can be made to adjust for increased severity of vasospasm and neurological exams.

Entities:  

Mesh:

Year:  2013        PMID: 23353891      PMCID: PMC3582678          DOI: 10.3791/4157

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  16 in total

1.  Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model.

Authors:  Hartmut Vatter; Stefan Weidauer; Juergen Konczalla; Edgar Dettmann; Michael Zimmermann; Andreas Raabe; Christine Preibisch; Friedhelm E Zanella; Volker Seifert
Journal:  Neurosurgery       Date:  2006-06       Impact factor: 4.654

2.  Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats.

Authors:  H Suzuki; K Kanamaru; H Tsunoda; H Inada; M Kuroki; H Sun; S Waga; T Tanaka
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

3.  The time course of intracranial pathophysiological changes following experimental subarachnoid haemorrhage in the rat.

Authors:  A Jackowski; A Crockard; G Burnstock; R R Russell; F Kristek
Journal:  J Cereb Blood Flow Metab       Date:  1990-11       Impact factor: 6.200

4.  Inhibitory effect with antisense mitogen-activated protein kinase oligodeoxynucleotide against cerebral vasospasm in rats.

Authors:  Motoyoshi Satoh; Andrew D Parent; John H Zhang
Journal:  Stroke       Date:  2002-03       Impact factor: 7.914

5.  Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage.

Authors:  Jin-Yul Lee; Oren Sagher; Richard Keep; Ya Hua; Guohua Xi
Journal:  Neurosurgery       Date:  2009-08       Impact factor: 4.654

6.  Signal transduction pathways in cerebral vasospasm.

Authors:  Alexander Y. Zubkov; Anil Nanda; John H. Zhang
Journal:  Pathophysiology       Date:  2003-01

7.  Neurologic evaluation in a canine model of single and double subarachnoid hemorrhage.

Authors:  M Kaoutzanis; M Yokota; R Sibilia; J W Peterson
Journal:  J Neurosci Methods       Date:  1993-12       Impact factor: 2.390

8.  Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat.

Authors:  J B Bederson; I M Germano; L Guarino
Journal:  Stroke       Date:  1995-06       Impact factor: 7.914

9.  Experimental subarachnoid hemorrhage: cerebral blood flow and brain metabolism during the acute phase in three different models in the rat.

Authors:  Giselle Fabiana Prunell; Tiit Mathiesen; Niels-Aage Svendgaard
Journal:  Neurosurgery       Date:  2004-02       Impact factor: 4.654

10.  Subarachnoid hemorrhage fails to produce vasculopathy or chronic blood flow changes in rats.

Authors:  D M Swift; R A Solomon
Journal:  Stroke       Date:  1988-07       Impact factor: 7.914

View more
  4 in total

1.  Erythropoietin Inhibits the Increase of Pulmonary Labile Zinc and the Expression of Inflammatory Mediators Following Subarachnoid Hemorrhage in Rats.

Authors:  Yiting Zhou; Xudong Zhao; Yanna Tang; Lin Zhu; Jianwei Jiang; Xiaojie Lu
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

2.  Endothelin-1 expression and alterations of cerebral microcirculation after experimental subarachnoid hemorrhage.

Authors:  Qin Lei; Shu Li; Ruibin Zheng; Ke Xu; Songbai Li
Journal:  Neuroradiology       Date:  2014-10-05       Impact factor: 2.804

3.  Ultrasound guided double injection of blood into cisterna magna: a rabbit model for treatment of cerebral vasospasm.

Authors:  Yongchao Chen; Youzhi Zhu; Yu Zhang; Zixuan Zhang; Juan Lian; Fucheng Luo; Xuefei Deng; Kelvin K L Wong
Journal:  Biomed Eng Online       Date:  2016-02-06       Impact factor: 2.819

4.  Valproic Acid Reduces Vasospasm through Modulation of Akt Phosphorylation and Attenuates Neuronal Apoptosis in Subarachnoid Hemorrhage Rats.

Authors:  Chieh-Hsin Wu; Yi-Cheng Tsai; Tai-Hsin Tsai; Keng-Liang Kuo; Yu-Feng Su; Chih-Hui Chang; Chih-Lung Lin
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.